An Engineered Receptor-Binding Domain Improves the Immunogenicity of Multivalent SARS-CoV-2 Vaccines.
Guo Y, He W, Mou H, Zhang L, Chang J, Peng S, Ojha A, Tavora R, Parcells MS, Luo G, Li W, Zhong G, Choe H, Farzan M, Quinlan BD.
Guo Y, et al. Among authors: li w.
mBio. 2021 May 11;12(3):e00930-21. doi: 10.1128/mBio.00930-21.
mBio. 2021.
PMID: 33975938
Free PMC article.